Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? | Zendy

D. M. Livermore | Zendy; Russell Hope | Zendy; Rosy Reynolds | Zendy; Ruth Blackburn | Zendy; A. P. Johnson | Zendy; N. Woodford | Zendy

Open Access

Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?

Author(s) -

D. M. Livermore,

Russell Hope,

Rosy Reynolds,

Ruth Blackburn,

A. P. Johnson,

N. Woodford

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt212

Subject(s) - cephalosporin , enterobacteriaceae , microbiology and biotechnology , antibacterial agent , antibiotics , medicine , biology , escherichia coli , genetics , gene

The UK saw major increases in cephalosporin and quinolone resistance amongst Enterobacteriaceae from 2001 to 2006, with cephalosporin resistance largely reflecting dissemination of CTX-M extended-spectrum β-lactamases (ESBLs). We review subsequent trends.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research